Inventor · disambiguated record
Weidong Liu
Also filed as: LIU WEIDONG
16 granted patents·5 pending applications·124 citations·filing 2006–2021
92Inventor score
Top patents by PatentIndex Score
21 records- 0194US8299021B2Macrocyclic inhibitors of hepatitis C virus replicationBLATT LAWRENCE M·Filed 2012·Granted Oct 30, 2012·47 cites·2 claims
- 0293US7829665B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2006·Granted Nov 9, 2010·27 cites·29 claims
- 0390US8648087B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesLYSSIKATOS JOSEPH P·Filed 2006·Granted Feb 11, 2014·24 cites·37 claims
- 0488US9382212B1Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2015·Granted Jul 5, 2016·6 cites·24 claims
- 0587US9238627B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2013·Granted Jan 19, 2016·7 cites·14 claims
- 0684US10745419B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2018·Granted Aug 18, 2020·2 cites·19 claims
- 0784US9598376B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2016·Granted Mar 21, 2017·3 cites·14 claims
- 0884US9562016B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2015·Granted Feb 7, 2017·3 cites·16 claims
- 0982US9980944B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2017·Granted May 29, 2018·2 cites·12 claims
- 1081US11098064B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrileLOXO ONCOLOGY INC·Filed 2020·Granted Aug 24, 2021·1 cites·9 claims
- 1178US10398683B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2017·Granted Sep 3, 2019·1 cites·23 claims
- 1273US10729678B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2019·Granted Aug 4, 2020·0 cites·1 claims
- 1369US11807651B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
- 1466US10835533B21 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitorARRAY BIOPHARMA INC·Filed 2015·Granted Nov 17, 2020·1 cites·5 claims
- 1562US2009169510A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2008·Application pending·0 cites
- 1658US2009148407A1Novel Macrocyclic Inhibitors of Hepatitis C Virus ReplicationINTERMUNE INC·Filed 2006·Application pending·0 cites
- 1749US2018282324A1Crystalline forms of a pyrrolopyridine compoundGENENTECH INC·Filed 2017·Application pending·0 cites
- 1844US10329288B2Process for preparing a compoundGENENTECH INC·Filed 2014·Granted Jun 25, 2019·0 cites·20 claims
- 1944US2016251350A1Crystalline forms of a pyrrolopyridine compoundGENENTECH INC·Filed 2016·Application pending·0 cites
- 2042US11760709B2Method for preparing resorcinol through micro-channel reactionINNER MONGOLIA SHENG TANG INTERNATIONAL MONGOLIAN MEDICINE RES INSTITUTE CO LTD·Filed 2021·Granted Sep 19, 2023·0 cites·8 claims
- 2140US2022132846A11-pyridyl-pyrazolyl amide compounds and preparation and uses thereofHUNAN RES INSTITUTE OF CHEMICAL INDUSTRY CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weidong Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →